ERBB2 and breast carcinoma: TNBCs are characterized with the absence of three hormone receptors namely, progesterone, estrogen, and HER-2 TNBC accounts for 15-20 % of all breast cancer cases, and patients with it typically have a worse prognosis than those with the other breast cancer subtypes (Obidiro et al., 2023[50]).